Luminex LX200 IVD System

The National Institutes of Health intends to award a Firm-Fixed-Price Purchase Order to Luminex Corp for the Luminex LX200 IVD System. This system is a flow-based bead reader platform required for high-throughput, multiplexed genomic and proteomic biomarker analysis. The system is necessary for the Clinical Trials Correlative Laboratory Core/Center for Cancer Research at the National Cancer Institute to perform simultaneous detection of up to 100 analytes in a single reaction volume. • The system's xMAP technology allows for comprehensive biomarker profiling while conserving precious clinical specimens. • The inclusion of the 21 CFR Part 11 compliance module ensures that all data generated from these clinical trials meets the stringent regulatory standards for data integrity and electronic records. • The notice is not a request for competitive quotes, but small businesses may submit a written capability statement to demonstrate their ability to perform the requirement.